
Thousands of people will now be able to receive a novel weight-reduction injection in the UK, after the medicines watchdog became the first major regulator to greenlight the drug in a more convenient device.
The medication, also known as tirzepatide, was approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) late last year for the treatment of obesity and type 2 diabetes.